ASO Author Reflections: Is Sentinel Node Biopsy Still of Value for Patients with High-Risk Primary Melanomas Eligible for Adjuvant Immunotherapy?

Pennington TE, Thompson JF, Varey AHR. Annals of Surgical Oncology, (Dec 27 2024), doi:10.1245/s10434-024-16821-5.

No abstract available.